N-((S)-1-(3-(4-chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bR,4aS)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide

Categoria API Impurità del lenacapavir
Forma Off White Solid
Numero CAT DCTI-C-004614
Numero CAS 3060953-29-6
Nome IUPAC N-((S)-1-(3-(4-chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bR,4aS)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide
Formula molecolare C39H32CLF10N7O5S2
Peso molecolare 968.28
solubilità acetonitrile
Condizioni di conservazione 2-8 ° C
Sinonimi Impurità del diastereomero del lenacapavir (miscela di atropisomeri)

India

Daicel Chiral Technologies (India) Pvt. Ltd
Rilievo n. 542/2, IKP Knowledge Park
Turkapally, Shamirpet Mandal, Medchal-Malkajgiri
Distretto di Hyderabad 500101, Telangana, India
Al servizio di ASEA, India, SAARC,
Medio Oriente, CSI

Torna in Cima
Il prodotto è stato aggiunto al tuo carrello